OrganaBio
David Quint is an experienced professional with a diverse background in finance, real estate, and biotechnology. Currently serving as a Partner at GridVest Partners since June 2023, David specializes in the distribution and financing of commercial and industrial stationary battery storage systems. In addition to this role, David has been the Non-Executive Chairman at OrganaBio, LLC since June 2018, overseeing the provision of tissue and cell products for the pharmaceutical industry. As a Director at Quartz Properties since July 2017, David focuses on developing attainable modern housing using modular technology. David also serves as a Director at ImmunoTek Bio Centers, LLC, facilitating the development of FDA-approved plasma donation centers. Previous experience includes key leadership roles at Bayview Asset Management, LLC, Bayview Italia, S.r.L., and Bayview Financial, along with significant positions at Lehman Brothers and Citi. David holds a Bachelor of Science in Physics from UC San Diego and an MBA in Finance from The Wharton School.
This person is not in any teams
This person is not in any offices
OrganaBio
1 followers
OrganaBio is a CDMO that offers an integrated solution of supply chain, development, and manufacturing resources specifically for cell therapy developers. OrganaBio offers its clients a broad array of expertise across a range of disciplines, including Biomedical Engineering, Cell Biology, Tissue Engineering, Regenerative Medicine, Cell and Gene Therapy, Drug Development, Immunology and Analytical Chemistry.